Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors

Summary

Curavit Clinical Research acquired CRO assets from Lindus Health to expand clinical trial capabilities across the U.S. and Europe, enhancing recruitment and evidence generation services for pharma, biotech, medtech, and related sectors.